Nucleic Acid Extraction Equipment Market

Nucleic Acid Extraction Equipment Market Report, By Product Type (Automated Nucleic Acid Extraction Systems, Manual Nucleic Acid Extraction Systems, Reagents and Consumables), By Application (Genomic DNA Extraction, RNA Extraction, Plasmid DNA Extraction, Viral DNA and RNA Extraction, Others) and Regions 2024-2032

Market Overview:

"The global nucleic acid extraction equipment market size reached US$ 758.1 million in 2023. Looking forward, Reports and Insights expects the market to reach US$ 1,528.1 million in 2032, exhibiting a growth rate (CAGR) of 8.1% during 2024-2032."

Global nucleic acid extraction equipment market growth and market share is driven by steady sales and increasing demand for nucleic acid as a result of rising prevalence of infectious diseases, genetic disorders, and cancer. Nucleic acid extraction procedures in research, diagnostics, and therapeutics is increasing as a result of research-backed initiatives in countries across the globe.

Major advancements in molecular biology techniques, such as PCR and DNA sequencing, are further driving demand for nucleic acid extraction equipment. Also, increasing focus on precision medicine and personalized healthcare regimes has been opening up opportunities for companies operating in the market. In addition, steady adoption of automated extraction systems, integration of robotics and artificial intelligence, and development of more cost-effective and user-friendly extraction kits are trends ongoing in the market.

Nucleic Acid Extraction Equipment Market Report Overview:

The report provides comprehensive insights into driving factors, restraints, opportunities, and trends, with provision of in-depth supporting information, data, statistics, and actionable insights. Though covered and provided extensively across the report, the data and information format are simple, yet dynamic in order to ensure ease of reading and understanding, as well as presenting and maximizing leverage and use.

Revenues are provided in detail for previous years in order to showcase the evidence upon which our estimations and forecasts are based. Revenue growth rates and differences, as well as comparisons and relatable data are provided to further support all findings. Data points are provided for each year – from historical to end of forecast period – and this format is followed for each segment region and respective countries, as well as sub-segments and others. Vital details of major companies in the market are provided in the company profile section of the report. Cover includes financials, recent developments, strategies, product launches, agreements, expansion, mergers & acquisitions, and others.  

The report is segmented according to type, application, technology, throughput, workflow and regions. Regional segmentation includes North America (United States and Canada); Europe (Germany, United Kingdom, France, Italy, Spain, Russia, Poland, BENELUX, NORDIC, and Rest of Europe); Asia Pacific (China, India, Japan, South Korea, ASEAN, Australia & New Zealand, & Rest of Asia Pacific); Latin America (Brazil, Mexico, Argentina, & Rest of Latin America); Middle East & Africa (Saudi Arabia, South Africa, United Arab Emirates, Egypt, Israel, and Rest of MEA).

Some more detailed insights on the market are provided below:

Increasing Prevalence of Infectious Diseases and Genetic Disorders: Global nucleic acid extraction equipment market research is driven by various factors that have been considered and analysed to arrive at accurate conclusions. We have considered factors such as rising prevalence of infectious diseases, genetic disorders, and chronic conditions, among others. These factors are resulting in increased demand for nucleic acid extraction procedures for accurate diagnosis, monitoring, and treatment.

Advancements in Molecular Biology Techniques: Advancements in molecular biology techniques, such as Polymerase Chain Reaction (PCR), Deoxyribonucleic Acid (DNA) sequencing, and gene expression analysis, are causing a surge in demand for nucleic acid extraction equipment. These techniques require high-quality nucleic acids, and increasing focus on R&D initiatives in healthcare and molecular biology are driving the need for efficient extraction systems.

Shift towards Personalized Medicine and Precision Healthcare: Rising focus on personalized medicine and precision healthcare has created opportunities for the major growth of the nucleic acid extraction equipment market. Tailored treatment plans based on individual genetic profiles require accurate and efficient nucleic acid extraction to analyze specific genetic variations. Increasing focus in these fields is expected to contribute significantly to increase in market size over the forecast period.

Automation and Integration of Robotics: Steady trend towards automation and integration of robotics in nucleic acid extraction equipment is another factor expected to support increase in market size. Automated systems offer higher throughput, increased efficiency, and reduced human error. This enables laboratories to process large volumes of samples in a shorter time, improving workflow and productivity.

Development of User-Friendly and Cost-Effective Extraction Kits: Development of user-friendly and cost-effective nucleic acid extraction kits. These kits simplify the extraction process, and are accessible to a wider range of users, including smaller laboratories and Point-Of-Care (POC) settings. Availability of cost-effective kits address affordability issues and can result in widespread adoption or preference over conventional nucleic acid extraction equipment.

What Factors Are Restraining Growth of Nucleic Acid Extraction Equipment Market?

Revenue growth of the market is restrained by several factors, some of which are provided in some detail below:

High Cost of Equipment: The high cost associated with nucleic acid extraction equipment is a significant restraint to market growth. The initial investment required for purchasing and maintaining the equipment can be a barrier, especially for smaller laboratories or healthcare facilities with limited budgets.

Complexity of Equipment Operation: Nucleic acid extraction equipment ideally requires skilled personnel and specialized training for operation. The complexity of the equipment and need for technical expertise can limit adoption, particularly in resource-limited settings or facilities with limited access to skilled operators.

Challenges in Sample Preparation: The effectiveness of nucleic acid extraction depends on proper sample preparation, including sample collection, storage, and transport. Challenges in sample handling, such as sample degradation, contamination, or insufficient sample volume, can negatively impact the extraction process and result in compromised outcomes.

Limited Standardization: Lack of standardized protocols and quality control measures for nucleic acid extraction can hinder consistent and reliable results across different laboratories and settings. This lack of standardization poses challenges in comparing and replicating study findings, leading to potential inconsistencies in research and diagnostics.

Competition from Alternative Technologies: Growth of the nucleic acid extraction equipment market is also restrained by competition from alternative technologies and methods for nucleic acid extraction, some of which include magnetic bead-based extraction, solid-phase extraction, and column-based extraction. These alternatives offer different advantages, including ease of use, faster extraction times, and lower costs, which can impact adoption of traditional nucleic acid extraction equipment.

What are the Opportunities for Leading Nucleic Acid Extraction Equipment Manufacturers?

Growing Demand for Molecular Diagnostics: Increasing demand for molecular diagnostic tests, such as PCR-based assays and Next-Generation Sequencing (NGS), presents a significant opportunity for companies operating in the nucleic acid extraction equipment market. As these diagnostic methods become more prevalent in research and clinical settings, demand for efficient and reliable nucleic acid extraction equipment is expected to rise.

Expansion in Biotechnology and Pharmaceutical Research: Steadily expanding biotechnology and pharmaceutical sectors are driven by advancements in genomics, personalized medicine, and drug development, and this is creating favorable scenarios for growth of the nucleic acid extraction equipment market share. Companies can capitalize on this opportunity by offering innovative and automated extraction solutions that streamline the research and development processes.

High Focus on Infectious Disease Diagnostics: Ongoing global health crises, such as the COVID-19 pandemic, have underscored the importance of rapid and accurate diagnostic testing for infectious diseases. Nucleic acid extraction equipment plays a crucial role in the extraction of viral or bacterial genetic material for detection and diagnosis. The heightened focus on infectious disease diagnostics presents a significant opportunity for companies to expand their market presence.

Rising Adoption of Point-of-Care Testing: Increasing demand for Point-Of-Care testing, where diagnostic tests are performed in proximity of the patient for immediate results, provides an opportunity for nucleic acid extraction equipment manufacturers. Portable and user-friendly extraction equipment that can be integrated into point-of-care testing platforms allows for quick and accurate nucleic acid extraction at the bedside or in remote settings.

Technological Advancements and Automation: Continuous advancements in nucleic acid extraction technologies, including development of automated systems and robotic platforms, offer opportunities for research companies and others to improve workflow efficiency, reduce manual errors, and enhance extraction accuracy. Automation enables higher throughput, standardized processes, and reduced turnaround time, making nucleic acid extraction equipment more lucrative for laboratories and research facilities.

What are the factors driving the Nucleic Acid Extraction Equipment demand in North America region?

Nucleic acid extraction equipment market research on North America shows factors such as high adoption of advanced molecular diagnostic techniques and genomics research, the region's well-established healthcare infrastructure, presence of major biotechnology companies, and increasing demand for precision medicine are contributing significantly to market revenue growth.

Does Europe account for a prominent Nucleic Acid Extraction Equipment market share?

Rising demand for nucleic acid extraction equipment in countries in Europe is driven by rising prevalence of chronic diseases and increasing focus on personalized medicine. The region has a strong presence of pharmaceutical and biotechnology companies, research institutions, and government support for genomic research are key factors driving market growth.

What are the factors driving the growth in Nucleic Acid Extraction Equipment sales in Asia Pacific region?

The nucleic acid extraction equipment market in Asia Pacific is witnessing significant growth due to increasing healthcare expenditure, rising investments in research and development activities, and growing adoption of advanced molecular diagnostic technologies. Initiatives and advancements in countries such as China, Japan, and India are driving market growth, with focus on precision medicine and genomics research being high on the list of focus areas.

What is the Outlook on Nucleic Acid Extraction Equipment Sales in Latin America?

Latin America market revenue growth is driven by steady demand for nucleic acid extraction equipment as a result of inclining prevalence of infectious diseases and the need for accurate and rapid diagnostics. Government initiatives to improve healthcare infrastructure, along with collaborations between academic institutions and biotech companies, are further supporting market growth in the region.

Why Middle East & Africa region is characterized by a diverse market landscape?

The nucleic acid extraction equipment market in the Middle East & Africa is expanding due to rising awareness about genomics research, increasing healthcare expenditure, and presence of pharmaceutical and biotechnology companies. Rising focus on improving healthcare infrastructure and advancements in molecular diagnostics in countries in the region is also expected to contribute to market revenue growth.

Leading Nucleic Acid Extraction Equipment Manufacturers & Competitive Landscape:

The global nucleic acid extraction equipment market is highly competitive and fragmented, with several key players accounting for substantial market share. These companies are actively engaging in product development, technological advancements, strategic collaborations, and mergers and acquisitions to strengthen their market position. The competitive landscape is characterized by intense competition, high level focus on innovation, and major emphasis on meeting customer demands for efficient and reliable nucleic acid extraction equipment.

Company List:

  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Agilent Technologies, Inc.
  • Danaher Corporation
  • Merck KGaA
  • Promega Corporation
  • Tecan Group Ltd.
  • Zymo Research Corporation
  • PerkinElmer, Inc.
  • Analytik Jena AG
  • Hamilton Company
  • Beckman Coulter, Inc.
  • Takara Bio Inc.

Major Companies & Recent Developments:

  • Thermo Fisher Scientific Inc. announced the launch of its MagMAX Microbiome Ultra Nucleic Acid Isolation Kit in November 2021, providing a comprehensive solution for microbial DNA and RNA extraction.
  • QIAGEN N.V. introduced its QIAcube Connect Plus system in April 2022. This system is a next-generation automated sample processing system for nucleic acid extraction, offering improved flexibility and connectivity.
  • Bio-Rad Laboratories, Inc. launched its Reliance One-Step Multiplex Supermix in September 2021. The kit is a high-performance reverse transcription polymerase chain reaction (RT-PCR) kit for nucleic acid detection.
  • F. Hoffmann-La Roche Ltd. announced the acquisition of GenMark Diagnostics, Inc. in April 2021, and this move enables the company to expand its nucleic acid testing portfolio and strengthening its position in the molecular diagnostics market.
  • Agilent Technologies, Inc. introduced the Agilent SureSelect XT HS2 DNA Kit in February 2022, enabling efficient and high-quality DNA extraction for next-generation sequencing applications.

Research Scope

Report Metric

Report Details

Market size available for the years   


Base Year


Forecast Period       


Compound Annual Growth Rate (CAGR)


Segment covered 

Type, Application, Technology, Throughput, Workflow and Regions.

Regions Covered

North America:  The U.S. & Canada


Latin America: Brazil, Mexico, Argentina, & Rest of Latin America


Asia Pacific: China, India, Japan, Australia & New Zealand, ASEAN, & Rest of Asia Pacific


Europe: Germany, The U.K., France, Spain, Italy, Russia, Poland, BENELUX, NORDIC, & Rest of Europe


The Middle East & Africa:  Saudi Arabia, United Arab Emirates, South Africa, Egypt, Israel, and Rest of MEA 

Fastest Growing Country in Asia-pacific


Largest Market in Europe


Key Players

Thermo Fisher Scientific Inc., QIAGEN N.V., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Agilent Technologies, Inc., Danaher Corporation, Merck KGaA, Promega Corporation, Tecan Group Ltd., Zymo Research Corporation, PerkinElmer, Inc., Analytik Jena AG, Hamilton Company, Beckman Coulter, Inc., Takara Bio Inc.

Report Segmentation:

Product Type:

  • Automated Nucleic Acid Extraction Systems
  • Manual Nucleic Acid Extraction Systems
  • Reagents and Consumables


  • Magnetic Bead-based Extraction
  • Silica-based Extraction
  • Column-based Extraction
  • Others


  • Research Institutes and Academia
  • Hospitals and Diagnostic Centers
  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations (CROs)
  • Forensic Laboratories
  • Others


  • Genomic DNA Extraction
  • RNA Extraction
  • Plasmid DNA Extraction
  • Viral DNA and RNA Extraction
  • Others


  • Manual Extraction
  • Automated Extraction


  • High-throughput Extraction Systems
  • Medium-throughput Extraction Systems
  • Low-throughput Extraction Systems

Segmentation By Region:

North America:

  • United States
  • Canada


  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
  • Russia
  • Poland
  • Rest of Europe

Asia Pacific:

  • China
  • Japan
  • India
  • South Korea
  • Australia & New Zealand
  • Rest of Asia Pacific

Latin America:

  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America

Middle East & Africa:

  • Saudi Arabia
  • South Africa
  • United Arab Emirates
  • Israel
  • Rest of MEA

Frequently Asked Question

Please Fill Your Details

Your personal details will remain secure and confidential. Privacy Policy